Southern Acids (malaysia) Bhd. · MYX:SAB

Southern Acids (malaysia) Bhd — Southern Acids (M) Berhad — Shareholder Meeting (September 2020)

16 slides from Southern Acids (malaysia) Bhd's shareholder meeting presentation, Sep 25, 2020

  1. Slide 1: 39th Annual General Meeting Shareholders Briefing

    SOUTHERN ACIDS (M) BERHAD 39TH ANNUAL GENERAL MEETING 25 SEPTEMBER 2020 SHAREHOLDERS BRIEFING

  2. Slide 2: Source of Information & Disclaimer

    SLIDE 1 SOURCE OF INFORMATION & DISCLAIMER Source of Information Used For The Presentation  The Company’s 2020 Annual Report; and  All other information that are available from Bursa Malaysia Securities Berhad’s website. Disclaimer Information contained in this presentation is intended solely for

  3. Slide 3: Presentation Contents

    SLIDE 2 PRESENTATION CONTENTS 1. Southern Acids (M) Berhad (“SAB” or “the Company”) & Its Subsidiaries (“SAB Group”) a. SAB Group’s Key Financial Highlights For The Financial Year Ended 31 March 2020 (“FY2020”); and b. SAB Group’s Financial Performance For The FY2020 2. SAB Group’s Segments a. Revie

  4. Slide 4: SAB Group's Key Financial Highlights for FY2020

    SOUTHERN ACIDS (M) BERHAD SAB GROUP’S KEY FINANCIAL HIGHLIGHTS FOR FY2020

  5. Slide 5: SAB Group's Key Financial Highlights

    SLIDE 3 SAB GROUP’S KEY FINANCIAL HIGHLIGHTS FY2020 FY2019 (RM’000) (RM’000) Revenue 660,286 598,645 Profit Before Tax (“PBT”) 48,740 38,574 Profit For The Year 39,229 25,468 Earnings Per Share 23.4 sen 15.7 sen Dividend (Net) 5.0 sen 5.0 sen Dividend Pay-out Ratio 17.4% 26.9%

  6. Slide 6: SAB Group's Key Financial Highlights (Cont'd)

    SLIDE 4 SAB GROUP’S KEY FINANCIAL HIGHLIGHTS (CONT’D) FY2020 FY2019 (RM’000) (RM’000) Total Assets 727,388 731,557 Net Current Assets 310,861 280,610 Total Liabilities 77,166 75,542 Equity Attributable To 594,422 601,281 Shareholders Of The Company

  7. Slide 7: SAB Group's Financial Performance (Cont'd)

    SLIDE 5 SAB GROUP’S FINANCIAL PERFORMANCE (CONT’D) FY2020 FY2019 Changes RM’000 RM’000 RM’000 Group’s Revenue 660,286 598,645 61,641 Group’s PBT 48,740 38,574 10,166 Segments’ PBT Milling & Estate 28,037 16,627 11,410 Healthcare 25,410 22,997 2,413 Oleochemical (3,219) (2,445) (774) Factors For The

  8. Slide 8: Review of the Respective Segments' Financial Performance

    SOUTHERN ACIDS (M) BERHAD REVIEW OF THE RESPECTIVE SEGMENTS’ FINANCIAL PERFORMANCE

  9. Slide 9: Oleochemical Segment Financial Performance

    SLIDE 6 OLEOCHEMICAL SEGMENT FINANCIAL PERFORMANCE FY2020 FY2019 Changes RM’000 RM’000 RM’000 Revenue 282,410 290,651 (8,241) LBT Core LBT (5,210) (7,099) (1,889) Non-Core PBT 1,991 4,654 (2,663) (3,219) (2,445) (774) Highlights: - Core LBT 1. Lower revenue due to lower ASP for fatty acids (7.3%) an

  10. Slide 10: Oleochemical Segment Outlook for FY2021

    SLIDE 7 OLEOCHEMICAL SEGMENT OUTLOOK FOR FY2021 Challenging, key factors are as follows:- 1. External factors;  Challenges and uncertainties surrounding the global economy as the world enters the recovery phase from the impact of Covid-19;  Competition from industry peers with larger production ca

  11. Slide 11: Milling & Estate Segment Financial Performance

    SLIDE 8 MILLING & ESTATE SEGMENT FINANCIAL PERFORMANCE FY2020 FY2019 Changes RM’000 RM’000 RM’000 Revenue 269,453 205,796 63,657 PBT Core PBT 19,413 11,497 7,916 Non-Core PBT 8,624 5,130 3,494 28,037 16,627 11,410 Highlights: - Core PBT 1. Higher revenue attributed from an increase in volume of FFB

  12. Slide 12: Milling & Estate Segment – Outlook for FY2021

    SLIDE 9 MILLING & ESTATE SEGMENT – OUTLOOK FOR FY2021 Challenging, the performance of this segment is largely subjected to the following uncontrollable factors:-  Challenges and uncertainties surrounding the global economy as the world enters the recovery phase from the impact of Covid-19 ;  Commo

  13. Slide 13: Healthcare Segment Financial Performance

    SLIDE 10 HEALTHCARE SEGMENT FINANCIAL PERFORMAMCE FY2020 FY2019 Changes RM’000 RM’000 RM’000 Revenue 91,365 84,216 7,149 PBT Core PBT 22,635 20,115 2,520 Non-Core PBT 2,775 2,882 (107) 25,410 22,997 2,413 Highlight: - Core PBT 1. Higher core PBT reflective of higher revenue; and 2. Higher revenue du

  14. Slide 14: Healthcare Segment Outlook for FY2021

    SLIDE 11 \ HEALTHCARE SEGMENT OUTLOOK FOR FY2021 Continue to enjoy stable growth, driven by the following factors:- 1. External factors; Concerns over the pandemic overhang 2. Internal factors; Improving our service levels which include constant upgrading and refurbishing of the existing facilities

  15. Slide 15: SAB Group Outlook for FY2021

    SLIDE 12 SAB GROUP OUTLOOK FOR FY2021 In short, it remains challenging, especially due to concerns over the economic uncertainties, Both locally and globally, in wake of the Covid-19 pandemic.

  16. Slide 16: Questions & Answers

    SOUTHERN ACIDS (M) BERHAD QUESTIONS & ANSWERS

Southern Acids (M) Berhad — Shareholder Meeting (September 2020) on 6ix